mitoxantrone has been researched along with Esophagotracheal Fistula in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lymphoma is an unusual cause of tracheoesophageal fistula (TEF)." | 1.29 | Tracheoesophageal fistula developing during chemotherapy for non-Hodgkins lymphoma. ( Bierman, PJ; Galbraith, TA; Lackner, RP, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lackner, RP | 1 |
| Bierman, PJ | 1 |
| Galbraith, TA | 1 |
1 other study available for mitoxantrone and Esophagotracheal Fistula
| Article | Year |
|---|---|
Tracheoesophageal fistula developing during chemotherapy for non-Hodgkins lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Lymphoma, Large B-C | 1996 |